After the Biopsy Result

We know not all prostate cancers are the same. 


Today it is becoming more and more important to obtain additional information about each patient’s specific disease in order to make the best treatment decision possible.

Metamark offers a range of proven, advanced resources to provide enhanced information post-biopsy:

Positive/Malignant biopsy result

  • Biopsy Gleason Scores 3+3 and 3+4: ProMark

  • Atypical/HGPIN or Gleason Scores 3+3 and 3+4: PTEN/ERG    

Negative/Benign biopsy result

Next: Making the RIGHT treatment decision
ProMark: Proteomics Prognostic Test for Prostate Cancer

ProMark, a first-of-its-kind  proteomic prognostic test for biopsy Gleason Scores 3+3 and 3+4.

Gain CONFIDENCE for better treatment decisions.

                                                                  LEARN MORE

Improve your biopsy decisions.
Reduce the number of unnecessary repeat biopsies.

                                                                  LEARN MORE